RIPARIAN PHARMACEUTICALS, INC.

Follow

Organization

Cambridge, MA, US

Organizations

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
INDUCERS OF KLF2 AND METHODS OF USE THEREOF
- Publication number 20250171460
- Publication date May 29, 2025
- Riparian Pharmaceuticals, Inc.
- Michael Serrano-Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KLF2 INDUCING DEUTERATED COMPOUNDS AND USES THEREOF
- Publication number 20250109143
- Publication date Apr 3, 2025
- Riparian Pharmaceuticals, Inc.
- Michael Serrano-Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 7

Research Projects

Information Research Project
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
- Application id 9490431
- Award notice date Jun 7, 2018
Information Research Project
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
- Application id 9335712
- Award notice date May 25, 2017
Information Research Project
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
- Application id 9391426
- Award notice date Mar 15, 2017
Information Research Project
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
- Application id 9141224
- Award notice date Aug 20, 2016
Information Research Project
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis
- Application id 8918093
- Award notice date Sep 15, 2014
Information Research Project
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis
- Application id 8719164
- Award notice date Jul 25, 2014
Information Research Project
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis
- Application id 8523086
- Award notice date Aug 9, 2013